Literature DB >> 25697254

[Pediatric asthma control and quality of life questionnaires].

Alberto Vidal G.   

Abstract

The assessment of symptoms and quality of life are important aspects in the control of childhood asthma. Questionnaires regarding symptoms control and quality of life give valuable information about the disease from the perspective of the child and his family. The aim of this study is to discuss the most important characteristics of this type of questionnaire such as age range, language of validation, number of questions, administration mode, the evaluated period and fields, and the minimum clinically relevant difference. The ACT questionnaires, for children older than 11 years of age, and CAN questionnaires, for children between 2 and 14 years of age in their Spanish versions, are suitable for measuring asthma control in our country. Regarding quality of life, PAQLQ for children between 7 and 17 years of age and PACQLQ for their care givers are the most popular oversees; Spanish versions have been adapted for Chile.

Entities:  

Mesh:

Year:  2014        PMID: 25697254     DOI: 10.4067/S0370-41062014000300013

Source DB:  PubMed          Journal:  Rev Chil Pediatr        ISSN: 0370-4106


  2 in total

1.  Determinants for asthma control, quality of life and use of complementary and alternative medicine in asthmatic pediatric patients in four cities.

Authors:  Kam Lun Hon; Yan Min Bao; Kate C Chan; Kin Wai Chau; Rong-Shan Chen; Kun Tat Gary Cheok; Wa Keung Chiu; Li Deng; Chun-Hui He; Kin Mui Ieong; Jeng Sum C Kung; Ping Lam; Shu Yan David Lam; Qun Ui Lee; So Lun Lee; Ting Fan Leung; Theresa N H Leung; Lei Shi; Ka Ka Siu; Wei-Ping Tan; Maggie Haitian Wang; Tak Wai Wong; Bao-Jing Wu; Ada Y F Yip; Yue-Jie Zheng; Daniel K Ng
Journal:  World J Pediatr       Date:  2018-07-25       Impact factor: 2.764

2.  Effectiveness and safety of 3 different traditional Chinese therapies for asthma in minors: A protocol for systematic review and network meta-analysis.

Authors:  Shi Fan Yan; Ting Yu; Fu Sheng Li; Yong Huang; Mao Hong Wang
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.